Different vaccine very soon available to people under 60, instead of AstraZeneca Vaccination with AstraZeneca will continue for people aged 60 years and older; the vaccine is still very necessary for that target group.
Vaccination with AstraZeneca continues for people aged 60 years and older As advised by the Health Council of the Netherlands, vaccination with AstraZeneca will be continued for people born in 1960 or before. People under the age of 60 will receive a different vaccine.
Fewer coronavirus infections among people who kept distancing People who follow the advice to stay 1.5 apart from others are less likely to contract the coronavirus SARS-CoV-2.
Coronavirus monitoring in sewage research expanded and extended Since March 2020, RIVM has been working with the water boards in the Netherlands to monitor sewage for traces of the coronavirus SARS-CoV-2. The measurements are an important supplement to other COVID-19 studies.
New hold on vaccination with AstraZeneca for people under 60 years The Ministry of Health, Welfare and Sport (VWS) has decided to stop vaccinating with the COVID-19 vaccine made by AstraZeneca for people under 60 (born in 1961 or later), effectively from now until Wednesday.
Staying 1.5 metres apart is growing more difficult Staying 1.5 metres apart seems to be more and more difficult for people to manage.
Mortality still significantly elevated between 30 April and 6 May, but much lower than in previous weeks The total mortality rate in the Netherlands was significantly elevated in the week of 30 April to 6 May 2020. However, excess mortality was much lower than in previous weeks.
The 1.5-metre society is difficult to maintain Personal hygiene measures, such as not shaking hands, or using paper tissues, are not considered a problem by most Dutch people.
COVID-19 in nursing homes is stabilising The number of new nursing homes with COVID-19 patients is stabilising.
Rapid diagnostic tests are not reliable The Serology Task Force of the National Coordination Centre for Testing Capacity – a partnership between RIVM, hospitals and laboratories – has collected research results on rapid diagnostic tests